sharmila koppisetti, MD

Trials

Studies that name sharmila koppisetti, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:49 UTC. Open this list on ClinicalTrials.gov

• Ph1/Ph2
  NCT05218408 · CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type

  Celularity Incorporated · withdrawn · Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma · study director
• Ph1
  NCT04489420 · Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM

  Celularity Incorporated · terminated · Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme · study director
• Ph2
  NCT02264288 · Efficacy and Safety of Intramuscular PDA-002 in Subjects With Diabetic Foot Ulcer With and Without PAD.

  Celularity Incorporated · terminated · Peripheral Arterial Disease, Diabetic Foot · study director
• Ph1
  NCT01859117 · Study of PDA-002 in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcers

  Celularity Incorporated · completed · Peripheral Arterial Disease, Diabetic Foot Ulcer · study director
• Ph2
  NCT01155362 · PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's Disease

  Celularity Incorporated · completed · Crohn's Disease · study director

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:49 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 20 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.